Health Care & Life Sciences » Biotechnology | Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc. | Ownership

Companies that own Aldeyra Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Perceptive Advisors LLC
3,085,458
14.71%
0
0.59%
06/30/2018
Fidelity Management & Research Co.
1,611,311
7.68%
0
0%
06/30/2018
683 Capital Management LLC
1,000,000
4.76%
0
0.96%
06/30/2018
Sphera Funds Management Ltd.
846,935
4.04%
-162,196
1.03%
06/30/2018
Adage Capital Management LP
750,000
3.58%
0
0.01%
06/30/2018
Millennium Management LLC
724,952
3.46%
-28,191
0.01%
06/30/2018
The Vanguard Group, Inc.
722,174
3.44%
28,946
0%
06/30/2018
BlackRock Fund Advisors
703,091
3.35%
666,188
0%
06/30/2018
Mangrove Partners
434,344
2.06%
110,325
0.56%
06/30/2018
SSgA Funds Management, Inc.
236,626
1.12%
210,695
0%
06/30/2018

About Aldeyra Therapeutics

View Profile
Address
131 Hartwell Avenue
Lexington Massachusetts 02421
United States
Employees -
Website http://www.aldeyra.com
Updated 07/08/2019
Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes. The company was founded by Thomas A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.